Oral pilocarpine for the treatment of ocular symptoms in patients with Sjögren's syndrome: a randomised 12 week controlled study.

Abstract

OBJECTIVE To evaluate the efficacy and side effects of oral pilocarpine for the treatment of ocular symptoms in patients with primary Sjögren's syndrome (SS). METHODS A 12 week, single centre, randomised controlled study was performed. Twenty nine patients were randomly assigned to receive oral pilocarpine (5 mg twice a day), 28 only artificial tears, and… (More)

Topics

Cite this paper

@article{Tsifetaki2003OralPF, title={Oral pilocarpine for the treatment of ocular symptoms in patients with Sj{\"{o}gren's syndrome: a randomised 12 week controlled study.}, author={Niki Tsifetaki and Georgios Kitsos and Constantinos Paschides and Yannis Alamanos and Vasilios Eftaxias and Paraskevi V. Voulgari and Konstantinos G. Psilas and Alexandros A. Drosos}, journal={Annals of the rheumatic diseases}, year={2003}, volume={62 12}, pages={1204-7} }